Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation: Evidence From 9713 Endomyocardial Biopsies

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.647149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.

  2005cited by this paper
• Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors.

  2005cited by this paper
• Small vessel disease after heart transplantation: impact of immunologic and nonimmunologic risk factors *

  2005cited by this paper
• Cardiac allograft vasculopathy after heart transplantation: risk factors and management.

  2004cited by this paper
• The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.

  2004cited by this paper
• Role of B cells and macrophages in microvascular disease after heart transplantation.

  2004cited by this paper
• Diagnostic accuracy of coronary angiography and risk factors for post–heart-transplant cardiac allograft vasculopathy

  2003cited by this paper
• Shear stress and vascular remodeling: study of cardiac allograft coronary artery disease as a model of diffuse atherosclerosis.

  2002cited by this paper
• Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.

  2002cited by this paper
• Correlation of angiographic and immunohistochemical findings in graft vessel disease after heart transplantation.

  2001cited by this paper
• Transplant Vasculopathy: a Model for Coronary Artery Disease?

  2000cited by this paper
• Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome

  2000cited by this paper
• Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy.

  2000cited by this paper
• Light microscopic biopsy findings after heart transplantation and possible links to development of graft vessel disease.

  1999cited by this paper
• Role of endomyocardial biopsy in the diagnosis of chronic rejection in human heart transplantation

  1997cited by this paper
• Cardiac allograft vasculopathy: a review.

  1997cited by this paper
• Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts.

  1996cited by this paper
• Does intracoronary ultrasound conflict with pathology? Comments from a panel discussion.

  1995cited by this paper
• Cardiac allograft vasculopathy: current concepts.

  1995cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.

  1995cited by this paper
• The pathogenesis of coronary arteriosclerosis (“chronic rejection”) in transplanted hearts

  1994cited by this paper
• Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience.

  1992cited by this paper
• Transplant coronary artery disease: histopathologic correlations with angiographic morphology.

  1991cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Graft coronary disease: the lesions and the patients.

  1989cited by this paper
• Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

  1989cited by this paper
• Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.

  1988cited by this paper
• Morphological changes in small vessels on endomyocardial biopsy.

  1986cited by this paper
• HEART GRAFT ARTERIOSCLEROSIS: AN OMINOUS FINDING ON ENDOMYOCARDIAL BIOPSY

  1985cited by this paper
• [Angiometric examination of veins and arteries in various age groups].

  1958cited by this paper

• Comprehensive non-invasive assessment of cardiac allograft vasculopathy and myocardial involvement in heart transplant patients using cardiac computed tomography.

  2026cites this paper
• Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor Dysfunction.

  2026cites this paper
• Index microvascular resistance (IMR) in heart transplant patients (IMR-HT study): Study protocol

  2025cites this paper
• Microvascular Resistance Reserve and Prognosis After Heart Transplantation.

  2025cites this paper
• Thriving Long-Term After Heart Transplantation.

  2025cites this paper
• Early Evaluation of Cardiac Allograft Vasculopathy With Myocardial Blood Flow PET/CT: How Early Is Too Early?

  2024cites this paper
• Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences.

  2023cites this paper
• Pre-existing non-human leukocyte antigen antibodies are associated with allograft rejection after thoracic transplantation.

  2023cites this paper
• Invasive Coronary Physiology in Heart Transplant Recipients: State-of-the-Art Review

  2023cites this paper
• CT Coronary Angiography and Dynamic CT Myocardial Perfusion for Detection of Cardiac Allograft Vasculopathy.

  2023cites this paper
• Cardiac PET Myocardial Blood Flow Quantification Assessment of Early Cardiac Allograft Vasculopathy.

  2023cites this paper
• The Potential Role of CT Coronary Angiography and Dynamic CT MPI to Detect Early Cardiac Allograft Vasculopathy.

  2023cites this paper
• Ghrelin May Inhibit Inflammatory Response and Apoptosis During Ischemia-Reperfusion Injury.

  2022cites this paper
• Increased fibrosis and microvessel disease in allograft endomyocardial biopsies of children with chronic graft failure due to cardiac allograft vasculopathy.

  2022cites this paper
• Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.

  2022cites this paper
• Coronary Flow Evaluation in Heart Transplant Patients Compared to Healthy Controls Documents the Superiority of Coronary Flow Velocity Reserve Companion as Diagnostic and Prognostic Tool

  2022cites this paper
• Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation

  2021cites this paper
• Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis

  2021cites this paper
• Evaluation of cardiac allograft vasculopathy by positron emission tomography

  2021cites this paper
• Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantation

  2021cites this paper
• Koronární nemoc srdečního štěpu v současnosti

  2021cites this paper
• Micro‐ and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients—An exploratory study

  2020cites this paper
• Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy

  2020cites this paper
• Impact of rejection-related immune responses on the initiation and progression of cardiac allograft vasculopathy.

  2020cites this paper
• Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy

  2020cites this paper
• Chronic Rejection

  2020cites this paper
• Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

  2020cites this paper
• Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.

  2020cites this paper
• Functional tricuspid valve insufficiency after cardiac transplantation: Which factor is the most important?

  2020cites this paper
• Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients

  2020cites this paper
• Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation

  2020influential citation
• Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts

  2020cites this paper
• Statin intensity and risk for cardiovascular events after heart transplantation

  2020cites this paper
• Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm

  2019cites this paper
• ACE2 and ACE in acute and chronic rejection after human heart transplantation.

  2019cites this paper
• Exosomes expressing the self‐antigens myosin and vimentin play an important role in syngeneic cardiac transplant rejection induced by antibodies to cardiac myosin

  2018cites this paper
• The role of exosomes in allograft immunity.

  2018cites this paper
• PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.

  2018cites this paper
• Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy

  2018cites this paper
• The Coronary Circulation in Cardiomyopathies and Cardiac Allografts

  2017cites this paper
• Significance and Value of Endomyocardial Biopsy Based on Our Own Experience.

  2017cites this paper
• Large-scale 3-dimensional quantitative imaging of tissues: state-of-the-art and translational implications.

  2017cites this paper
• Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?

  2017cites this paper
• Cardiac Transplantation and the Contribution of Pathology

  2016cites this paper
• Index of microvascular resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial.

  2016cites this paper
• Serial changes in longitudinal graft function and implications of acute cellular graft rejections during the first year after heart transplantation.

  2016cites this paper
• Graft Failure/Dysfunction: Clinical Issues and Role of Endomyocardial Biopsy

  2016cites this paper
• Noninvasive Detection of Cardiac Allograft Vasculopathy by Stress Exercise Echocardiographic Assessment of Myocardial Deformation.

  2016cites this paper
• Microvascular integrity plays an important role for graft survival after experimental skin transplantation.

  2015cites this paper
• Physical exercise reduces transplant arteriosclerosis in a mouse aorta transplantation model.

  2015cites this paper
• Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection

  2015cites this paper
• Chronische Abstoßung

  2015cites this paper
• Development of a molecular toolbox to study the cross-talk between Angiotensin II type 1 and Endothelin-1 type A receptors in the context of obliterative vasculopathy

  2015cites this paper
• Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

  2015cites this paper
• Everolimus prevents coronary microvasculopathy in heart transplant recipients with normal coronary angiograms: an anatomo-functional study.

  2014cites this paper
• Cardiac allograft vasculopathy: diagnosis, therapy, and

  2014cites this paper
• Veränderungen des Interstitiums des Myokards nach Herztransplantation (Computerbasierte Mikroskopbildanalyse des interstitiellen Gewebes von Kontrollendomyokardbiopsien nach Herztransplantation)

  2014cites this paper
• Increased Negative Impact of Donor HLA-Specific Together With Non-HLA–Specific Antibodies on Graft Outcome

  2014cites this paper
• Immunosuppression-state-of-the-art: anything new in the pipeline?

  2014cites this paper
• Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation

  2014cites this paper
• Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis

  2014cites this paper
• State of the art in paediatric heart transplantation: the Berlin experience.

  2013cites this paper
• Mechanisms of chronic cardiac allograft rejection.

  2013cites this paper
• Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation.

  2013cites this paper
• Impact of donor benign intimal thickening on cardiac allograft vasculopathy.

  2013cites this paper
• The Transplanted Heart

  2013cites this paper
• New tissue biomarkers of Antibody Mediated Rejection in Heart Transplantation

  2012cites this paper
• Arrhythmia Post Heart Transplantation

  2012cites this paper
• Non-HLA Antibodies Targeting Vascular Receptors Enhance Alloimmune Response and Microvasculopathy After Heart Transplantation

  2012cites this paper
• Endomyocardial Sampling in Cardiac Allografts'' With Intracoronary Flow Velocity and Pressure Measurements: Validation With Letter by Hiemann et al Regarding Article, ''Assessment of Microcirculatory Remodeling

  2012cites this paper
• Oral Nicorandil for Prevention of Cardiac Death in Hemodialysis Patients without Obstructive Coronary Artery Disease: A Propensity-Matched Patient Analysis

  2011cites this paper
• Cardiomyocyte-targeted HIF-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat.

  2010cites this paper
• International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Vasculites e lesões isquêmicas imunomediadas como fatores preditores de mau prognóstico no transplante cardíaco

  2010cites this paper
• Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model.

  2009cites this paper
• Strain‐Encoded Cardiac Magnetic Resonance for the Evaluation of Chronic Allograft Vasculopathy in Transplant Recipients

  2009cites this paper
• Microvasculopathy observed in early or late endomyocardial biopsies is not related to angiographically confirmed transplanted heart coronary vasculopathy.

  2009cites this paper
• Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?

  2009cites this paper
• Quilty effect, acute cellular rejection, and transplant vasculopathy: still controversial.

  2009cites this paper
• Re: Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.

  2009cites this paper
• Cytomegalovirus infection does not accelerate microvasculopathy development in heart transplant recipients.

  2009cites this paper
• Cardiac allograft vasculopathy: recent developments.

  2008cites this paper
• Beneficial Effect of Female Gender on Long-Term Survival After Heart Transplantation

  2008cites this paper
• Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients.

  2008cites this paper